ALL	Acute lymphoblastic leukemia;
ANZCCSG	Australian and New Zealand Children’s Cancer Study Group;
ANZCHOG	Australian and New Zealand Children’s Hematology and Oncology Group;
BFM	Berlin-Frankfurt-Münster;
CI	Confidence interval;
COG	Children’s Oncology Group;
CVL	Central venous line;
CVST	Cerebral venous sinus thrombosis;
DVT	Deep venous thrombosis;
ERASE	Evaluation of Risk of ALL Treatment-Related Side-Effects;
GWAS	Genome-wide association study;
GWS	Genome-wide significance;
LBL	Lymphoblastic lymphoma;
LD	Linkage disequilibrium;
MAF	Minor allele frequency;
MPAL	Mixed-phenotype acute leukemia;
NOPHO	Nordic Society of Pediatric Hematology and Oncology;
NCI-CTCAE	National Cancer Institute Common Terminology Criteria for Adverse Events;
OR	Odds ratio;
SD	Standard deviations;
SNP	Single-nucleotide polymorphism;
PE	Pulmonary embolus;
VTE	Symptomatic venous thromboembolism.